Aptorum Group: Funding, Investors & Team (Sep 2026)
At Aptorum, we believe that by facilitating the development of medical innovations, particularly in those that able to meet current unmet medical needs and significantly improve clinical and surgical experience, is inevitable in advancing the quality of human life and patient care. With this vision, Mr. Ian Huen founded Aptorum, leveraging talented specialists and prosperous medical resources across the globe, to accelerate the evolution of potentially First-in-Class/Best-in-Class therapeutic and diagnostic innovations across a wide range of disease areas. By combining a broad pipeline of early stage novel medical innovations and multi-disciplinary human capital, Aptorum aims to become a world class player in the pharmaceutical industry with emphasis in science, collaboration and entrepreneurship.
Aptorum Group has raised $3.0M across 1 funding round on record, the most recent an undisclosed round of $3.0M announced in Dec 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aptorum Group Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Aptorum Group Funding Rounds
Aptorum Group Founders and Leadership Team
Contact details for the Aptorum Group team: 1 of 1 has an email address on file.
Start 14-day free trial →Aptorum Group Funding Compared to Other Biotechnology Startups
Aptorum Group's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aptorum Group in Biotechnology and London
Companies Similar to Aptorum Group
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Aptorum Group Funding FAQs
What does Aptorum Group do?
At Aptorum, we believe that by facilitating the development of medical innovations, particularly in those that able to meet current unmet medical needs and significantly improve clinical and surgical experience, is inevitable in advancing the quality of human life and patient care. With this vision, Mr. Ian Huen founded Aptorum, leveraging talented specialists and prosperous medical resources across the globe, to accelerate the evolution of potentially First-in-Class/Best-in-Class therapeutic and diagnostic innovations across a wide range of disease areas. By combining a broad pipeline of early stage novel medical innovations and multi-disciplinary human capital, Aptorum aims to become a world class player in the pharmaceutical industry with emphasis in science, collaboration and entrepreneurship.
How much funding has Aptorum Group raised?
Aptorum Group has raised $3.0M across 1 round on record. The most recent is an undisclosed round of $3.0M announced in Dec 2022.
When did Aptorum Group last raise funding?
Aptorum Group's most recent funding round on record is an undisclosed round of $3.0M, announced in Dec 2022.
Who is the CEO of Aptorum Group?
Ian Huen is listed as CEO at Aptorum Group.
Where is Aptorum Group headquartered?
Aptorum Group is based in London, England, United Kingdom.
How many employees does Aptorum Group have?
Aptorum Group is in the 11-50 employee band.
How does Aptorum Group's funding compare to other Biotechnology startups?
Aptorum Group's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Aptorum Group Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aptorum Group is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.